With the coronavirus pandemic growing rapidly, the company doesn't see drug studies as the best use of healthcare resources right now.
News & Analysis: Vertex Pharmaceuticals
Biotech companies have outperformed the general market -- and there are plenty of reasons to remain optimistic.
Stuck at home because of the COVID-19 outbreak? Make money over the long run by investing in these great stocks.
These biotechs' profits shouldn't be dented by the COVID-19 pandemic. And their growth prospects appear to be really good.
A rebounding stock market lifted all three of these biotech stocks.
Here are three great stocks to buy on the cheap.
Despite fears of a COVID-19 pandemic, these two stocks are worth considering.
The company has set terms for its initial public offering.
These stocks aren't likely to be infected with the current market worries.
Looking for great stocks to buy if the market rebounds in a big way? Think healthcare.